Phase II, Open-label, Parallel 2-arm, Multi-center

Oncology·MeSH: Pancreatic Neoplasms
0 drugs in development·0 companies·1 clinical trial

Deep-dive into Phase II, Open-label, Parallel 2-arm, Multi-center

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Phase II, Open-label, Parallel 2-arm, Multi-center — Drugs in Development & Clinical Trials | BioSniper